IART or PEN: Which Is the Better Value Stock Right Now?
Penumbra Inc PEN
$318.86
▼ -0.10%
($-0.32)
Open
$318.73
Prev Close
$319.18
Day Range
$318.14 – $318.98
52W Range
$221.26 – $362.41
Market Cap
$12.56B
P/E (TTM)
78.10
Beta
0.71
EPS (TTM)
$4.07
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 2015-09-18 |
| Shares Out. | 39,330,000 |
| Website | penumbrainc.com/ ↗ |
| Phone | 13025310855 |
| Employees | 4,700 |
| Revenue | $390.0M |
| Gross Profit | $264.9M |
| Net Income | $34.8M |
| Free Cash Flow | $215.9M |
| Total Assets | $1.97B |
| Total Liabilities | $444.0M |
| Equity | $1.53B |
About Penumbra Inc
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.
Penumbra Inc is a publicly traded company under the ticker symbol PEN on the NEW YORK STOCK EXCHANGE, INC., operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
20 analysts (2026-09-01)